Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of AnaptysBio (NasdaqGS:ANAB) with a Outperform ...

Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Zenas BioPharma (NasdaqGS:ZBIO) with a ...

Consumer downloads of apps like Cash App and Venmo dropped in the fourth quarter compared to the year-ago period, data from ...

Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating and $25 price target The stock’s current ...

Wolfe Research initiated coverage of 89bio (ETNB) with an Outperform rating and $15 price target. Considering how low the stock is currently ...

Investing.com - U.S. President Donald Trump's decision to impose tariffs on America's closest trading partners means that ...

On Tuesday, Wolfe Research adjusted its outlook on American Woodmark Corporation (NASDAQ:AMWD), downgrading the company's stock from Outperform to Peer Perform. The change in rating comes amid ...

Wolfe Research assumed coverage on shares of AnaptysBio (NASDAQ:ANAB – Free Report) in a research report sent to investors on Tuesday, Marketbeat Ratings reports. The brokerage issued an ...

On Wednesday, Wolfe Research analysts maintained their Peer Perform rating on shares of Snap Inc (NYSE: NYSE:SNAP), citing a mix of factors that could influence the company's future performance. While ...

On Tuesday, Wolfe Research adjusted its outlook on American Woodmark Corporation (NASDAQ:AMWD), downgrading the company's stock from Outperform to Peer Perform. The change in rating comes amid ...